why choose us

First received: May 05, 2023

Clinical Trial: A Relative Bioavailability Study of HRS9531 in Healthy Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 2 Diabetes

Study Type: INTERVENTIONAL


Official Title: A Relative Bioavailability Study of Single-dose, Randomized, Open-label, Single-period, Parallel Design of HRS9531 Injection Using Different Manufacturing Processes in Healthy Subjects

Brief Summary: The purpose of this study is to evaluate the relative bioavailability of the new formulation of HRS9531 injection between the original formulation of HRS9531 injection.

Read more